The interventional treatment of tricuspid valve disease has evolved in recent years thanks to new research and critical FDA approvals. Cardiologist Ryan Kaple, MD, reviewed this trend for a new video interview.
This type of tracking helps a practice understand how radiologists interact with AI, whether they're appropriately rejecting incorrect results, and if the technology is improving detection of important findings.
Tim Szczykutowicz, PhD, associate professor radiology, University of Wisconsin Madison, explains the new technology developments in GE HealthCare's FDA 510(k)-pending photon-counting CT scanner.
Intravascular lithotripsy is expected to see even wider adoption when lower-profile catheters are introduced and device costs start to drop, explained Samin Sharma, MD.
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
Rebecca Farrington and Sandy Coffta from Healthcare Administrative Partners explain how to best tackle real-world issues radiology practices are facing.
Raquel Roman, chair of the Radiology Business Management Association (RBMA) Young Professionals Committee, and director of growth at Essential Radiology, explains how the group mentors the next generation leaders.
Dave Walker, senior director of revenue cycle, Radiology Associates of North Texas, explains how his practice uses artificial intelligence for revenue cycle management during the Radiology Business Management Association (RBMA) 2024 meeting.
Alexander Fanaroff, MD, said the late-breaking BE ACTIVE clinical trial presented at ACC.24 offers a blueprint for how to get patients to be more physically active.
Biga, who originally trained as a nurse, specializes in the business side of cardiology. She also emphasized the increasing importance of AI and other new technologies.
